Loss of NF1 Alleles Distinguish Sporadic from NF1‐Associated Pilocytic Astrocytomas

Pilocytic astrocytomas classified as WHO grade I typically arise in childhood and upon complete surgical removal carry a favorable prognosis. Children with neurofibromatosis 1 (NF1) have a vastly increased risk for pilocytic astrocytomas, especially for those of the optic nerve. Using 4 intragenic NF1 microsatellite markers, we examined losses of NF1 alleles on the long arm of chromosome 17 in 12 NF1-associated and 25 sporadic pilocytic astrocytomas. The TP53 gene region on the short arm of chromosome 17 was also examined in these tumors using 3 markers. Loss of 1 NF1 allele was detected in 11 of 12 (92%) informative NF1-associated pilocytic astrocytomas. In contrast, only 1 of 24 informative (4%) sporadic pilocytic astrocytomas exhibited allelic loss in the NF1 region. Among the 11 NF1-associated tumors with NF1 loss, 5 had also lost alleles on 17p. The high rate of NF1 allele loss in NF1-associated pilocytic astrocytomas suggests a tumor initiating or promoting action of the NF1 gene in these patients. On the other hand, the much lower rate of NF1-allele loss in sporadic pilocytic astrocytomas argues for only minor importance of NF1 in that patient group. The present data support different mechanisms in the formation of NF1-associated and sporadic pilocytic astrocytomas.

[1]  D. Gutmann,et al.  Loss of neurofibromatosis 1 (NF1) gene expression in NF1‐associated pilocytic astrocytomas , 2000, Neuropathology and applied neurobiology.

[2]  A. Poustka,et al.  Comprehensive Allelotype and Genetic Analysis of 466 Human Nervous System Tumors , 2000, Journal of neuropathology and experimental neurology.

[3]  Webster K. Cavenee,et al.  Pathology and genetics of tumours of the nervous system. , 2000 .

[4]  L. Kluwe,et al.  Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. , 1999, Cancer genetics and cytogenetics.

[5]  R. Hofstra,et al.  High Frequency of TP53 Mutations in Juvenile Pilocytic Astrocytomas Indicates Role of TP53 in the Development of These Tumors , 1999, Brain pathology.

[6]  D. Lenartz,et al.  Quantitative analysis of NF1 and OMGP gene transcripts in sporadic gliomas, sporadic meningiomas and neurofibromatosis type 1-associated plexiform neurofibromas , 1999, Acta Neuropathologica.

[7]  Erwin G. Van Meir,et al.  Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay , 1998, International journal of cancer.

[8]  D. Louis,et al.  PTEN mutations in gliomas and glioneuronal tumors , 1998, Oncogene.

[9]  X. Estivill,et al.  Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. , 1997, American journal of human genetics.

[10]  B. Korf,et al.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. , 1997, JAMA.

[11]  D. Louis,et al.  Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas. , 1996, The American journal of pathology.

[12]  M. Berger,et al.  Prognostic significance of type 1 neurofibromatosis (von Recklinghausen Disease) in childhood optic glioma. , 1996, Neurosurgery.

[13]  J. Brockmöller,et al.  p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas. , 1996, Human pathology.

[14]  J. Charrow,et al.  Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. , 1995, The Journal of pediatrics.

[15]  S. Colman,et al.  Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene , 1995, Nature Genetics.

[16]  E. Alvord,et al.  Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment. , 1988, Journal of neurosurgery.